What is the relationship between benign prostatic hyperplasia and sexual function?

Sexual and Relationship Therapy

Volumn 19, Issue 4, 2004, Pages 431-443

  Sak, S C ^a   Eardley, Ian ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; DUTASTERIDE; FINASTERIDE; PLACEBO; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN;

AGING; CLINICAL TRIAL; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HUMAN; IMPOTENCE; LIBIDO DISORDER; MALE; MEDICAL RESEARCH; PATHOPHYSIOLOGY; PROSTATE HYPERTROPHY; REVIEW; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; URINARY TRACT DISEASE;

EID: 10644268551     PISSN: 14681994     EISSN: None     Source Type: Journal    
DOI: 10.1080/14681990412331317890     Document Type: Review

References (34)

1. Abrams, P. (1994). New words for old: lower urinary tract symptoms for 'Prostatism'. British Journal of Medicine, 308, 929-930.
2. Barry, M.J. (2001). Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia. Urology, 58(6, Supplement 1), 25-32.
3. Barry, M.J., Fowler, F.J., O'Leary, M.P., Bruskewitz, R.C., Holtgrewe, H.L. & Mebust, W.K. (1992). The American Urological symptom index for benign prostatic hyperplasia. Journal of Urology, 148, 1549-1557.
4. Barry, M.J., Fowler, F.J., O'Leary, M.P., Bruskewitz, R.C., Holtgrewe, H.L. & Mebust, W.K. (1995). Measuring disease specific health status in men with benign prostatic hyperplasia. Medical Care, 33, 145-155.
5. Berry, S.J., Coffey, D.S., Walsh, P.C. & Ewing, L.L. (1984). The development of human benign prostatic hyperplasia by age. Journal of Urology, 132, 474-479.
6. Blanker, M.H., Bohnen, A.M., Groeneveld, F.P., Bernsen, R.M., Prins, A., Thomas, S. & Bosch, J.L. (2001). Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. Journal of the American Geriatrics Society, 49, 436-442.
7. Boyle, P., Robertson, C., Mazzetta, C., Keech, M., Hobbs, R., Fourcade, R., Kiemeney, L. & Lee, C. (2003). The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study. BJU International, 92, 719-725.
8. Brookes, S.T., Donovan, J.L., Peters, T.J., Abrams, P. & Neal, D.E. (2002). Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial. BMJ, 324, (7345), 1059-1061.
9. Donovan, J.L., Abrams, P., Peters, T.J., Kay, H.E., Reynard, J., Chapple, C., de la Rosette, J.J. & Kondo, A. (1996). The ICS-'BPH' Study: the psychometric validity and reliability of the ICS-male questionnaire., 77, 554-562.
10. Emberton, M., Neal, D.E., Black, N., Fordham, M., Harrison, M., McBrien, M.P., Williams, R.E., McPherson, K. & Devlin, M.D. (1996). The effect of prostatectomy on symptom severity and quality of life. BJU International, 77, 233-247.
11. Feldman, H.A., Goldstein, I., Hatzichristou, D. G., Krane, R.J. & Mckinlay, J.B. (1994). Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. Journal of Urology, 151, 54-61.
12. Francisca, E.A., d'Ancona, F.C., Meuleman, E.J., Debruyne, F.M. & de la Rosette, J.J. (1999). Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. Journal of Urology, 161, 486-490.
13. Frankel, S.J., Donovan, J.L., Peters, T.I., Abrams, P., Dabhoiwala, N.F., Osawa, D. & Lin, A.T. (1998). Sexual dysfunction in men with lower urinary tract symptoms. Journal of Clinical Epidemiology, 51(8), 677-685.
14. Gacci, M., Bartoletti, R., Figlioli, S., Sarti, E., Eisner, B., Boddi, V. & Rizzo, M. (2003). Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study. BJU International, 91, 196-200.
15. Garraway, W.M., Collins, C.G. & Lee, R.J. (1991). High prevalence of benign prostatic hypertrophy in the community. Lancet, 338, 469-471.
16. Hansen, B.J., Flyger, H., Brasso, K., Schou, J., Nordling, J., Thorup Andersen, J., Mortensen, S., Meyhoff, H.H., Walter, S. & Hald, T. (1995). Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS) system for use in benign prostatic hyperplasia. Journal of Urology, 76, 451-458.
17. Hill, B., Belville, W., Bruskewitz, R., Issa, M., Perez-Marrero, R., Roehrborn, C., Terris, M. & Naslund, M. (2004). Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. Journal of Urology, 171, 2336-2340.
18. Höfner, K., Claes, H., De Reijke, T.M., Folkestad, B. & Speakman, M.J. for the European Tamsulosin Study Group (1999). Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. 36 335-341.
19. Lepor, H. (1998). Long-term evaluation of tamsulosin in benign prostatic hyperplasia: Placebo-controlled, double-blind extension of phase III trial. Urology, 51(6), 901-904.
20. Lepor, H., Williford, W.O., Barry, M.J., Brawer, M.K., Dixon, C.M., Gormley, G., Haakenson, C., Machi, M., Narayan, P. & Padley, R.J. (1996). The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. New England Journal of Medicine, 335, 533-539.
21. MacFarlane, G.J., Botto, H., Sagnier, P.P., Teilac, P., Richard, F. & Boyle, P. (1996). The relationship between sexual life and urinary condition in the French community. Journal of Clinical Epidemiology, 49, 1171-1176.
22. Marberger, M.J. (1998). Long term effects of finasteride in patients with benign prostatic hyperplasia: a double blinded, placebo controlled, multicenter study. Urology, 51, 677-686.
23. McConnell, J.D., Roehrborn, C.G., Bautista, O.M., Andriole, Jr, G.L., Dixon, C.M., Kusek, J.W., Lepor, H., Mcvary, K.T., Nyberg, Jr, L.M., Clarke, H.S., Crawford, E.D., Diokno, A., Foley, J.P., Foster, H.E., Jacobs, S.C., Kaplan, S.A., Kreder, K.J., Lieber, M.M., Lucia, M.S., Miller, G.J., Menon, M., Milam, D.F., Ramsdell, J.W., Schenkman, N.S., Slawin, K.M. & Smith, J.A., for the Medical Therapy of Prostatic Symptoms (MTOPS) Research Groups (2003). The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. New England Journal of Medicine, 349(25), 2387-2398.
24. Mebust, W.K., Holtgrewe, H.L., Cockett, A.T. & Peters, P.C. (1989). Transurethral Prostatectomy: immediate and postoperative complications. A prospective study of thirteen participating institutions evaluating 3885 patients. 141, 243-247.
25. Norby, B., Nielsen, H.V. & Frimodt-Moller, P.C. (2002). Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. 90, 853-862.
26. O'Leary, M.P., Fowler, F.J., Lenderking, W.R., Barber, B., Sagnier, P.P., Guess, H.A. & Barry, M.J. (1995). A brief male sexual function inventory for urology. Urology, 46, 697-706.
27. Richard, F., Lukac, B., Jardin, A., Lanson, Y., Chevret-Measson, M., Grange, J.C. & Navratil, H. (2000). Results of an epidemiological survey in 3500 French men aged 50 to 80 years with special attention to urinary symptoms, quality of life and sexual function. European Urology, 37, 10-15.
28. Roehrborn, C.G., Van Kerrebroeck, P. & Nordling, J. (2003). Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies. BJU International, 92, 257.
29. Rosen, R., Altwein, J., Boyle, P., Kirby, R.S., Lukacs, B., Meuleman, E., O'Leary, M.P., Puppo, P., Robertson, C. & Giuliano, F. (2003). Lower urinary tract symptoms and male sexual dysfunction: the Multinational Survey of the Aging Male (MSAM-7). European Urology, 44 6), 637-649.
30. Rosen, R.C., Riley, A., Wagner, G., Osterloh, I.H., Kirkpatrick, J. & Mishra, A. (1997). The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology, 49, 822-830.
31. Sak, S.C., Hussian, Z., Johnston, C. & Eardley, I. (2004). What is the relationship of between male sexual function and lower urinary tract symptoms (LUTS)? European Urology, September /October.
32. Tan, A.H., Gilling, P.J., Kennett, K.M., Frampton, C., Westenberg, A.M. & Fraundorfer, M.R. (2003). A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). Journal of Urology, 170, 1270-1274.
33. Wasson, J.H., Reda, D.J., Bruskewitz, R.C., Ellison, J., Keller, A.M. & Henderson, W.G. (1995). A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia: the Veteran Affairs Cooperative Study on Transurethral Resection of the Prostate. New England Journal of Medicine, 332, 75-79.
34. Wessells, H., Roy, J., Bannow, J., Grayhack, J., Matsumoto, A.M., Tenover, L., Herlihy, R., Fitch, W., Labasky, R., Auerbach, S., Parra, R., Rajfer, J., Culbertson, J., Lee, M., Bach, M.A. & Waldstreicher, J., PLESS Study Group (2003). Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia. Urology, 61(3), 579-584.